Patent details

Basic Information

Publication number:

EP3236991

PCT Application Number:

EP2015080969

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP158178475

PCT Publication Number:

WO2016102562

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

FGF21 DERIVATIVES AND USES THEREOF

French Title of Invention:

DÉRIVÉS FGF21 ET LEURS UTILISATIONS

German Title of Invention:

FGF21-DERIVATE UND VERWENDUNGEN DAVON

SPC Number:

Dates

Filing date:

22/12/2015

Grant date:

19/06/2019

EP Publication Date:

01/11/2017

PCT Publication Date:

30/06/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/06/2019

EP B1 Publication Date:

19/06/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

22/12/2019

Expiration date:

22/12/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/06/2019

 

 

Name:

Novo Nordisk A/S

Address:

Novo Allé, 2880 Bagsværd, Denmark (DK)

Inventor

1

Name:

SASS-ØRUM, Kristian

Address:

Denmark (DK)

2

Name:

WIECZOREK, Birgit

Address:

Denmark (DK)

3

Name:

OLSEN, Jørgen

Address:

Denmark (DK)

4

Name:

ANDERSEN, Birgitte

Address:

Denmark (DK)

5

Name:

TAGMOSE, Tina Møller

Address:

Denmark (DK)

Priority

Priority Number:

14199935

Priority Date:

23/12/2014

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 38/00; A61K 38/18; C07K 14/50; A61K 47/54;

Publication

European Patent Bulletin

Issue number:

201925

Publication date:

19/06/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages